TERT promoter mutations and MC1R status as tools for identifying candidates for adjuvant therapy in stage IIB–IIC melanoma: a retrospective single-center study of 153 patients.
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2026-01-01
|
| Serija: | EJC Skin Cancer |
| Online pristup: | http://www.sciencedirect.com/science/article/pii/S2772611826001515 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|